These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11961894)

  • 61. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets.
    Parojcić J; Vasiljević D; Ibrić S; Djurić Z
    Int J Pharm; 2008 May; 355(1-2):93-9. PubMed ID: 18226480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 Jun; 10(6):2211-21. PubMed ID: 23654347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Companion animal physiology and dosage form performance.
    Sutton SC
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms.
    Thelen K; Coboeken K; Willmann S; Dressman JB; Lippert J
    J Pharm Sci; 2012 Mar; 101(3):1267-80. PubMed ID: 22125236
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of bovine in vivo bioavailability of two sulfamethazine oral boluses exhibiting different in vitro dissolution profiles.
    Martinez MN; Kawalek JC; Howard KD; Ward JL; Marroum P; Marnane W; Bensley D; Pelsor FR; Hoag S; Tatavarti AS; Xie L; Fahmy R
    J Vet Pharmacol Ther; 2006 Dec; 29(6):459-67. PubMed ID: 17083449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug release from matrix tablets: physiological parameters and the effect of food.
    Nokhodchi A; Asare-Addo K
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1401-18. PubMed ID: 24970101
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.
    Ding X; Gueorguieva I; Wesley JA; Burns LJ; Coutant CA
    AAPS J; 2015 Nov; 17(6):1395-406. PubMed ID: 26126932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.
    Lex TR; Rodriguez JD; Zhang L; Jiang W; Gao Z
    AAPS J; 2022 Mar; 24(2):40. PubMed ID: 35277760
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Physiological parameters for oral delivery and in vitro testing.
    Mudie DM; Amidon GL; Amidon GE
    Mol Pharm; 2010 Oct; 7(5):1388-405. PubMed ID: 20822152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products - a PEARRL review.
    Guimarães M; Statelova M; Holm R; Reppas C; Symilllides M; Vertzoni M; Fotaki N
    J Pharm Pharmacol; 2019 Apr; 71(4):603-642. PubMed ID: 29971768
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.
    Lennernäs H
    Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In-Vitro Drug Dissolution Studies in Medicinal Compounds.
    Bozal-Palabiyik B; Uslu B; Ozkan Y; Ozkan SA
    Curr Med Chem; 2018; 25(33):4020-4036. PubMed ID: 29577852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dynamic dissolution: a step closer to predictive dissolution testing?
    McAllister M
    Mol Pharm; 2010 Oct; 7(5):1374-87. PubMed ID: 20698545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro-in vivo correlation strategy applied to an immediate-release solid oral dosage form with a biopharmaceutical classification system IV compound case study.
    Bredael GM; Bowers N; Boulineau F; Hahn D
    J Pharm Sci; 2014 Jul; 103(7):2125-2130. PubMed ID: 24890761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.